Related Experiment Videos
[Study on CCK-induced gallbladder emptying with real-time ultrasonography]
1Department of Gastroenterology, People's Hospital, Beijing Medical University.
Zhonghua Nei Ke Za Zhi
|June 1, 1995
Summary
Atropine significantly inhibits cholecystokinin-octapeptide (CCK-OP)-induced gallbladder emptying in healthy individuals. Patients with silent gallstones exhibit impaired gallbladder emptying compared to controls.
Area of Science:
- Gastroenterology
- Hepatobiliary Medicine
- Diagnostic Imaging
Background:
- Gallbladder function is crucial for digestion.
- Cholecystokinin-octapeptide (CCK-OP) stimulates gallbladder contraction.
- Impaired gallbladder emptying is associated with gallstone disease.
Purpose of the Study:
- To investigate the effect of atropine on CCK-OP-induced gallbladder emptying in normal subjects.
- To compare gallbladder emptying between patients with silent gallstones and healthy controls.
Main Methods:
- Real-time ultrasonography was used to assess gallbladder volume and emptying.
- Normal subjects received CCK-OP with and without atropine.
- Gallbladder emptying was measured in patients with silent gallstones and control subjects.
Main Results:
- Atropine significantly reduced CCK-OP-induced gallbladder emptying from 88.7% to 43.4% in normal subjects (P < 0.001).
- Fasting gallbladder volume was larger in silent gallstone patients (26.7 cm3) than controls (19.2 cm3) (P < 0.05).
- Gallbladder emptying was significantly lower in silent gallstone patients (44.0%) compared to controls (53.4%) (P < 0.01).
Conclusions:
- CCK-OP-induced gallbladder emptying is significantly inhibited by atropine.
- Patients with silent gallstones demonstrate impaired gallbladder emptying.
- These findings highlight the role of CCK-OP in gallbladder function and its impairment in gallstone disease.